Quantcast

Latest Pantoprazole Stories

2011-02-14 09:00:00

CHAPEL HILL, N.C., Feb. 14, 2011 /PRNewswire/ -- Thought Leader Select, a Research Triangle, NC firm focused on collaborations between the biopharmaceutical industry and the medical community, announces the launch of a new media partnership with biopharmaceutical industry blog Marketing4Health. The research and consulting firm (Thought Leader Select) has signed on to become the blog's exclusive sponsor, beginning February 14, 2011. With a growing international following and strong...

2011-02-08 16:00:00

MORRISTOWN, N.J., Feb. 8, 2011 /PRNewswire/ -- Actavis Group, an international generic pharmaceuticals company, today announced that it has received approval from the US Food & Drug Administration to market Pantoprazole Sodium Delayed-Release Tablets, USP. Distribution of the product will commence shortly. Pantoprazole Sodium Delayed-Release Tablets 20mg and 40mg, the generic equivalent of Protonix® 20mg and 40mg by Pfizer, had US sales of approximately $1.6...

2011-01-24 11:37:00

PITTSBURGH, Jan. 24, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Pantoprazole Sodium Delayed-release (DR) Tablets USP, 20 mg (base) and 40 mg (base), the generic version of Wyeth's Protonix® DR Tablets, a treatment for the irritation of the esophagus caused by gastroesophageal...

2010-11-01 06:00:00

ZURICH, Nov. 1, 2010 /PRNewswire/ -- Nycomed has acquired 51.34% of the shares of Guangdong Techpool Bio-Pharma Co., Ltd., a fast-growing Chinese pharmaceutical company based in Guangdong Acquisition demonstrates importance of China as a key part of Nycomed's emerging markets strategy Nycomed gains access to a leading, high quality manufacturer of biologic and protein-based drugs with international potential Creates enhanced commercialization base for Nycomed products including...

2010-07-19 03:21:00

ZURICH, July 19, 2010 /PRNewswire/ -- - Nycomed's Protonix(R) Patent Found Infringed and not Obvious - U.S. District Court for the District of New Jersey has Upheld Jury Findings - Nycomed Will Continue to Vigorously Pursue its Damage Claims Nycomed announced today that Judge Jose L. Linares of the U.S. District Court for the District of New Jersey has confirmed the jury verdict in favor of Nycomed and Pfizer Inc. The decision upholds the jury verdict issued on...

2010-05-25 14:53:00

Labeling changes will include new safety information SILVER SPRING, Md., May 25 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today warned consumers and health care professionals about a possible increased risk of fractures of the hip, wrist, and spine with high doses or long-term use of a class of medications called proton pump inhibitors. The product labeling will be changed to describe this possible increased risk. (Logo:...

2009-09-16 15:38:54

U.S. researchers suggest doctors may wish to limit acid reducer use for their ventilator patients. The study, published in Chest, also recommends if an acid reducer is needed, less powerful ranitidine -- Zantac, which inhibits gastric acid secretion -- be used. The analysis of 834 cardiothoracic surgery patients finds those on another popular stomach acid reducer -- pantoprazole -- are three times more likely to develop pneumonia. Acid-reducing drugs can make the stomach a more hospitable...

2009-09-14 10:21:39

A popular stomach-acid reducer used to prevent stress ulcers in critically ill patients needing breathing machine support increases the risk of those patients contracting pneumonia threefold, according to researchers at Wake Forest University School of Medicine. Hospital-acquired pneumonia is the leading cause of infection-related deaths in critically ill patients. It increases hospital stays by an average of seven to nine days, cost of care, and the risk of other complications. "As best we...

235723a280b231ce5aaaf1001dec26191
2009-05-19 14:43:40

The US Justice Department announced on Monday that it would work alongside 16 states in two whistleblower lawsuits against Madison, N.J.-based drugmaker Wyeth. Filed in federal court in Massachusetts, the lawsuits claim that Wyeth charged too much for Protonix, a stomach acid-suppressing drug, which resulted in millions of dollars being siphoned from state Medicaid programs. The Justice Department is seeking payment from Wyeth, which allegedly failed to pay hundreds of millions of dollars in...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related